Roquette


CRYSMEB

Methyl Betacyclodextrin


Kleptose Crysmeb is a new generation, low metylated betacyclodextrin which is a purified polydisperse product resulting from the controlled reaction of a methylation agent and native betacyclodextrin.  This unique patented product of Roquette has good water solubility, enhanced stability to form inclusion compounds and a good potential for biological tolerance.


Grade Description
Application

Crysmeb

Methyl Betacyclodextrin with low molar substitution

Suitable for encapsulation of low solubility, volatile or unstable active ingredients. Used for injectables, syrups, solutions and oral suspensions.